The company credited its molecular diagnostics and international businesses as drivers of new growth.
The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation.
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
The three-year trial used immunoassays and PCR testing, and found 335 Babesia microti positive samples among 89,153 blood donations.
Roche's PCR-based Cobas test is also being deployed at one blood center in the US and is proving to be highly accurate, the agency said.
The Cobas Zika test is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus in plasma specimens from human blood donors.
The new Kansas City-based center will provide national genomic profiling of blood donations to more precisely match donors and transplant recipients, and reduce adverse outcomes.
The study showed that introducing a synthetic molecule into the blood of mice could force cancer cells, but not normal cells, to express a detectable biomarker.
The real-time PCR assay is designed to detect and identify HIV, hepatitis B virus, and hepatitis C virus in donations of human whole blood and blood components.
NEW YORK (GenomeWeb) — Hologic reported after the close of the market on Wednesday a 6 percent increase in revenues for its fiscal fourth quarter, including a 2 percent uptick in revenues for its Diagnostics business.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.